Monitoring of patients given second-generation antipsychotic agents

被引：4
|
作者：
Olson, Kari L. [1 ]
Delate, Thomas
Duagn, Daniel J.
机构：
[1] Kaiser Permanente, Dept Pharm, Aurora, CO USA
[2] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80202 USA
来源：
PSYCHIATRIC SERVICES | 2006年 / 57卷 / 07期
关键词：
D O I：
10.1176/appi.ps.57.7.1045-a
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1045 / 1046
页数：2
相关论文
共 50 条
  • [41] PERSISTENT HYPERGLYCEMIA SECONDARY TO SECOND-GENERATION ANTIPSYCHOTIC MEDICATIONS
    Arrese, N. Soulages
    Middleman, A. B.
    Meyer, J. D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 382 - 383
  • [42] The influence of therapeutic drug monitoring (TDM) and objective symptom rating for prediction of antipsychotic response to second-generation antipsychotic drugs
    Nazirizadeh, Y.
    Hiemke, C.
    Vogel, F.
    Lieb, K.
    Leucht, S.
    Dragicevic, A.
    PHARMACOPSYCHIATRY, 2008, 41 (05) : 213 - 213
  • [43] Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics
    Weissman, Ellen M.
    Zhu, Carolyn W.
    Schooler, Nina R.
    Goetz, Raymond R.
    Essock, Susan A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (09) : 1323 - 1326
  • [44] Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration
    Lizheng Shi
    Haya Ascher-Svanum
    Yi-Ju Chiang
    Yingnan Zhao
    Vivian Fonseca
    Daniel Winstead
    BMC Psychiatry, 9
  • [45] Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration
    Shi, Lizheng
    Ascher-Svanum, Haya
    Chiang, Yi-Ju
    Zhao, Yingnan
    Fonseca, Vivian
    Winstead, Daniel
    BMC PSYCHIATRY, 2009, 9
  • [46] THE FIRST GENERATION AND SECOND-GENERATION ANTIPSYCHOTIC DRUGS AND THEIR PHARMACOLOGY IN TREATMENT OF SCHIZOPHRENIA
    Shaikh, Afroj Ayyaj
    Pawar, Jaydeep Babasaheb
    SURANAREE JOURNAL OF SCIENCE AND TECHNOLOGY, 2023, 30 (06): : 070068 - 1
  • [47] Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis
    Nolt, Valerie D.
    Kibler, Alexandra Victoria
    Wilkening, G. Lucy
    Fabian, Tanya J.
    PEDIATRIC DRUGS, 2017, 19 (02) : 139 - 146
  • [48] Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis
    Valerie D. Nolt
    Alexandra Victoria Kibler
    G. Lucy Wilkening
    Tanya J. Fabian
    Pediatric Drugs, 2017, 19 : 139 - 146
  • [49] Hypoglycemia associated with second generation antipsychotic agents
    Watanabe, J.
    Suzuki, Y.
    Fukui, N.
    Sugai, T.
    Ono, S.
    Tsuneyama, N.
    Ozdemir, V.
    Someya, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 111 - 111
  • [50] Predictors of second-generation antipsychotic-induced weight gain: a longitudinal study on antipsychotic-naive patients
    Sanchez, M. Bravo
    Pina-Camacho, L.
    Diaz-Caneja, C. M.
    Alvarez Blazquez, M.
    Arias, B.
    Bobes, J.
    Corripio, I.
    Rodriguez-Jimenez, R.
    Fraguas, D.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S64 - S65
12345